Why Not Dexcom?

I love Sens as a stock, but I was curious about what's to stop Dexcom from just reverse engineering the Eversense 365? Surely they have enough capital & experience in the field to do so. It might take awhile for them to get it approved, but if they did, wouldn't that just kill any advantage Sens has? What do you guys think?